These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 6853711)

  • 101. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 102. The effect of differentiation inducers on the sensitivity of two myeloid cell lines to natural killer (NK) cell-mediated lysis.
    Golden M; Dempsey RA; Mier JW; Parkinson DR
    Int J Immunopharmacol; 1983; 5(5):411-9. PubMed ID: 6197382
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE.
    Humbel M; Bellanger F; Fluder N; Horisberger A; Suffiotti M; Fenwick C; Ribi C; Comte D
    Front Immunol; 2021; 12():645478. PubMed ID: 33828555
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Studies on natural, antibody-dependent, and interleukin-2-activated killer-cell activity of a patient with mucolipidosis III as a test of the mannose-6-phosphate lytic acceptor hypothesis.
    Werkmeister JA; Pross HF
    J Clin Immunol; 1985 Jul; 5(4):228-38. PubMed ID: 2931446
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Suppression of target cell proliferation by natural killer cells.
    Júlíusson PB; Ogmundsdóttir HM
    Scand J Immunol; 1990 Nov; 32(5):471-82. PubMed ID: 2270432
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production.
    Hirai N; Hill NO; Motoo Y; Osther K
    Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):153-9. PubMed ID: 4050442
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Recombinant interferon alpha 2 stimulation of target-binding by natural killer cells.
    Heidemann E; Weber J; Schmidt H; Reichmann U
    Klin Wochenschr; 1986 Oct; 64(20):1036-40. PubMed ID: 3465970
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Suppressed natural killer cell activity in patients with euthyroid Graves' ophthalmopathy.
    Pedersen BK; Perrild H; Feldt-Rasmussen U; Christensen T; Klarlund K; Hansen JM
    Autoimmunity; 1989; 2(4):291-8. PubMed ID: 2491612
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
    Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Prevention and reversal of delta-9-tetrahydrocannabinol induced depression of natural killer cell activity by interleukin-2.
    Specter S; Rivenbark M; Newton C; Kawakami Y; Lancz G
    Int J Immunopharmacol; 1989; 11(1):63-9. PubMed ID: 2540100
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells.
    Punjabi CJ; Moore MA; Ralph P
    Cell Immunol; 1983 Apr; 77(1):13-22. PubMed ID: 6839366
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Serum factors which suppress natural cytotoxicity in cancer patients.
    Holmes E; Sibbitt WL; Bankhurst AD
    Int Arch Allergy Appl Immunol; 1986; 80(1):39-43. PubMed ID: 3957445
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Natural killer augmentation in systemic lupus erythematosus via a soluble mediator derived from human lymphocytes.
    Kaufman DB
    Arthritis Rheum; 1982 May; 25(5):562-7. PubMed ID: 7082401
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Augmentation of human natural cytotoxic cell activity by leukotriene B4 mediated by enhanced effector-target cell binding and increased lytic efficiency.
    Gagnon L; Girard M; Sullivan AK; Rola-Pleszczynski M
    Cell Immunol; 1987 Dec; 110(2):243-52. PubMed ID: 2826016
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Natural killer cells in systemic lupus erythematosus. Abnormal numbers and functional immaturity of HNK-1+ cells.
    Egan ML; Mendelsohn SL; Abo T; Balch CM
    Arthritis Rheum; 1983 May; 26(5):623-9. PubMed ID: 6687804
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus.
    Hudspeth K; Wang S; Wang J; Rahman S; Smith MA; Casey KA; ; Manna Z; Sanjuan M; Kolbeck R; Hasni S; Ettinger R; Siegel RM
    Clin Exp Immunol; 2019 May; 196(2):226-236. PubMed ID: 30693467
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Inhibition of natural killer cell activity by antigen-antibody complexes.
    Pedersen BK; Thomsen BS; Nielsen H
    Allergy; 1986 Nov; 41(8):568-74. PubMed ID: 3492939
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Phospholipase C treatment of certain human target cells reduces their susceptibility to NK lysis without affecting binding or sensitivity to lytic granules.
    Une C; Grönberg A; Axberg I; Jondal M; Orn A
    Cell Immunol; 1991 Mar; 133(1):127-37. PubMed ID: 1703925
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 2. Effect of exogenous PGE1 on spontaneous and interferon-induced natural killer.
    Merrill JE; Myers LW; Ellison GW
    J Neuroimmunol; 1983 Jun; 4(3):239-51. PubMed ID: 6189856
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Immunomodulation of natural killer activity by polyribonucleotides.
    Wiltrout RH; Salup RR; Twilley TA; Talmadge JE
    J Biol Response Mod; 1985 Oct; 4(5):512-7. PubMed ID: 4078596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.